Table 1.
Study ID | Country | Study design | Participants | Data source | Time | Outcomes reported | |||
Study population | Setting | Age | Guideline introduction | Years of follow-up | |||||
Tyrstrup et al 14 | Sweden | Observational | N=1 245 599* | PC | 1–12 Y | Routine care | 2010 | Pre: 2008 Post: 2013 |
Antibiotic prescription rate Type of antibiotic |
Palma et al 11 | Italy | Observational | N=4559 Npre=2692 Npost=1867 |
SC | 0–14 Y | Routine care | 2010 | Pre: 2007–2010 Post: 2011–2013 |
Antibiotic prescription rate Type of antibiotic |
Levy et al 9 | France | Observational | N=14 661 | SC | 6 M–2 Y | Routine care | 2011 | Pre1: November 2009–October 2010 Pre2: November 2010–October 2011 Post: November 2011–October 2012 |
Type of antibiotic |
McGrath et al 10 | USA | Observational | N=4 629 460 | SC | 3 M–12 Y | Insurance databases | 2004 | Pre: 2000–2003 Post1: 2005–2007 Post2: 2008–2011 |
Antibiotic prescription rate |
Coco et al 8 | USA | Observational | N=1114 Npre=584 Npost=530 |
PC+SC | 6 M–12 Y | Electronic surveys | 2004 | Pre: January 2002–June 2004 Post: July 2004–December 2006 |
Antibiotic prescription rate Type of antibiotic Analgesic prescription rate |
Thompson et al 13 | UK | Observational | N=464 845† | PC | 3 M–15 Y | Routine care | 2003 2004 |
Pre: 1999–2001 Post: 2005–2006 |
Antibiotic prescription rate |
Ríos et al 12 | Spain | Observational | N=200 Npre=102 Npost=98 |
PC | 2–15 Y | Routine care | 2001 | Pre: January–March 2000 Post: January–March 2002 |
Type of antibiotic |
*Number of patient years.
†Number included in total study period of 17 consecutive years, no specific information on number of children over 1999–2001 and 2005–2006 periods.
M, months; N, number of patients; N/A, not available; PC, primary care setting; SC, secondary care setting; Y, years.